BASILE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 202
EU - Europa 136
AS - Asia 107
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 447
Nazione #
US - Stati Uniti d'America 202
CN - Cina 55
SE - Svezia 49
IT - Italia 38
SG - Singapore 34
RU - Federazione Russa 19
IN - India 12
DE - Germania 11
NL - Olanda 7
IE - Irlanda 5
FI - Finlandia 4
HK - Hong Kong 3
ID - Indonesia 2
BE - Belgio 1
EU - Europa 1
GB - Regno Unito 1
GR - Grecia 1
PE - Perù 1
TR - Turchia 1
Totale 447
Città #
New York 35
Ashburn 27
Singapore 27
Boardman 21
Shanghai 18
Milan 15
Lawrence 11
Princeton 11
Pune 8
Guangzhou 7
Moscow 6
Dublin 5
Rome 5
Amsterdam 3
Dallas 3
Hanover 3
Hyderabad 3
Munich 3
Seattle 3
Turin 3
Washington 3
Beijing 2
Cancello e Arnone 2
Detroit 2
Helsinki 2
Hong Kong 2
Lappeenranta 2
Osio Sotto 2
Santa Clara 2
Shenzhen 2
Silver Spring 2
Taizhou 2
Ufa 2
Yogyakarta 2
Athens 1
Bengbu 1
Borås 1
Brussels 1
Buffalo 1
Busto Garolfo 1
Ferrara 1
Florence 1
Friesland 1
Gaithersburg 1
Haining 1
Jiaxing 1
Los Angeles 1
Manchester 1
Mountain View 1
Mumbai 1
Padova 1
Pisa 1
Qingdao 1
Redwood City 1
San Antonio 1
Temecula 1
Vaprio d'Adda 1
Wuxi 1
Totale 270
Nome #
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 31
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 29
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 28
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 27
A global approach to improving penile cancer care 25
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 25
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 23
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 22
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 22
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 21
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 21
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 21
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 20
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 20
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 20
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 19
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 18
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 16
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 15
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 14
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 14
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 11
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 11
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 10
null 1
Totale 484
Categoria #
all - tutte 5.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 3 1 0 0 0 0 0
2021/202224 0 5 0 6 2 0 1 0 1 0 0 9
2022/2023100 27 18 3 7 4 12 8 11 2 0 4 4
2023/2024241 12 20 22 19 15 47 1 40 5 9 14 37
2024/2025115 33 21 16 29 16 0 0 0 0 0 0 0
Totale 484